Literature DB >> 15178698

Electrophysiological, pharmacological, and molecular evidence for alpha7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons.

Jie Wu1, Andrew A George, Katherine M Schroeder, Lin Xu, Syndia Marxer-Miller, Linda Lucero, Ronald J Lukas.   

Abstract

Dopamine (DA) neurons located in the mammalian midbrain have been generally implicated in reward and drug reinforcement and more specifically in nicotine dependence. However, roles played by nicotinic acetylcholine receptors, including those composed of alpha7-subunits [alpha7-nicotinic acetylcholine receptors (nAChRs)], in modulation of DA signaling and in nicotine dependence are not clearly understood. Although midbrain slice recording has been used previously to identify functional alpha7-nAChRs, these preparations are not optimally designed for extremely rapid and reproducible drug application, and rapidly desensitized, alpha7-nAChR-mediated currents may have been underestimated or not detected. Here, we use patch-clamp, whole-cell current recordings from single neurons acutely dissociated from midbrain nuclei and having features of DA neurons to characterize acetylcholine-induced, inward currents that rapidly activate and desensitize, are mimicked by the alpha7-nAChR-selective agonist, choline, blocked by the alpha7-nAChR-selective antagonists, methyllycaconitine and alpha-bungarotoxin, and are similar to those of heterologously expressed, human alpha7-nAChRs. We also use reverse transcriptase-polymerase chain reaction, in situ hybridization, and immunocytochemical staining to demonstrate nAChR alpha7 subunit gene expression as message and protein in the rat substantia nigra pars compacta and ventral tegmental area. Expression of alpha7 subunit message and of alpha7-nAChR-mediated responses is developmentally regulated, with both being absent in samples taken from rats at postnatal day 7, but later becoming present and increasing over the next 2 weeks. Collectively, this electrophysiological, pharmacological, and molecular evidence indicates that nAChR alpha7 subunits and functional alpha7-nAChRs are expressed somatodendritically by midbrain DA neurons, where they may play important physiological roles and contribute to nicotine reinforcement and dependence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178698     DOI: 10.1124/jpet.104.070417

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  32 in total

1.  Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.

Authors:  Hai-Ying Zhang; Ming Gao; Qing-Rong Liu; Guo-Hua Bi; Xia Li; Hong-Ju Yang; Eliot L Gardner; Jie Wu; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.

Authors:  Janice W Smith; Adrian Mogg; Elisiana Tafi; Eleanor Peacey; Ian A Pullar; Philip Szekeres; Mark Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  2006-11-18       Impact factor: 4.530

3.  Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease.

Authors:  Brian W Leonard; Diego Mastroeni; Andrew Grover; Qiang Liu; Kechun Yang; Ming Gao; Jie Wu; David Pootrakul; Simone A van den Berge; Elly M Hol; Joseph Rogers
Journal:  J Comp Neurol       Date:  2009-07-20       Impact factor: 3.215

4.  Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area.

Authors:  M Garzón; A M Duffy; J Chan; M-K Lynch; K Mackie; V M Pickel
Journal:  Neuroscience       Date:  2013-08-15       Impact factor: 3.590

Review 5.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

6.  α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Mick'l Scadden; Joanna Gajewiak; Sean Christensen; Jon Lindstrom; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2012-08-22       Impact factor: 4.436

7.  Alpha6-containing nicotinic acetylcholine receptor is a highly sensitive target of alcohol.

Authors:  Fenfei Gao; Dejie Chen; Xiaokuang Ma; Sterling Sudweeks; Jordan T Yorgason; Ming Gao; Dharshaun Turner; Jason Brek Eaton; J Michael McIntosh; Ronald J Lukas; Paul Whiteaker; Yongchang Chang; Scott C Steffensen; Jie Wu
Journal:  Neuropharmacology       Date:  2019-01-30       Impact factor: 5.250

8.  A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.

Authors:  Qiang Liu; Yao Huang; Fenqin Xue; Alain Simard; Jamie DeChon; Guohui Li; Jianliang Zhang; Linda Lucero; Min Wang; Michael Sierks; Gang Hu; Yongchang Chang; Ronald J Lukas; Jie Wu
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

9.  α6 subunit-containing nicotinic receptors mediate low-dose ethanol effects on ventral tegmental area neurons and ethanol reward.

Authors:  Scott C Steffensen; Samuel I Shin; Ashley C Nelson; Stephanie S Pistorius; Stephanie B Williams; Taylor J Woodward; Hyun Jung Park; Lindsey Friend; Ming Gao; Fenfei Gao; Devin H Taylor; M Foster Olive; Jeffrey G Edwards; Sterling N Sudweeks; Lori M Buhlman; J Michael McIntosh; Jie Wu
Journal:  Addict Biol       Date:  2017-09-13       Impact factor: 4.280

10.  Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons.

Authors:  Kechun Yang; Jun Hu; Linda Lucero; Qiang Liu; Chao Zheng; Xuechu Zhen; Guozhang Jin; Ronald J Lukas; Jie Wu
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.